FDA Names and Shames Drug Makers to Encourage Generic Competition - New York Times

New York TimesFDA Names and Shames Drug Makers to Encourage Generic CompetitionNew York TimesPharmac

» » FDA Names and Shames Drug Makers to Encourage Generic Competition - New York Times , ago, 11 view
Subscribe to our Facebook Bot


New York Times

FDA Names and Shames Drug Makers to Encourage Generic Competition
New York Times
Pharmaceutical companies that spend billions of dollars to develop new drugs do not want competitors to profit from inexpensive generic copies of blockbuster medicines. To avoid rivals, they fight for patent extensions, seek new uses for old products ...

and more »

Read more

2018-05-18T07:53:45Z 250250
Dragplus